Patents by Inventor Barbara KIDON

Barbara KIDON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2,2,2-trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene] method of making the same
    Patent number: 11584711
    Abstract: Crystalline polymorph forms of neurotrophic agent 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide (J147), and process for producing the crystalline polymorphic form are provided.
    Type: Grant
    Filed: January 17, 2021
    Date of Patent: February 21, 2023
    Assignee: ABREXA PHARMACEUTICALS, INC.
    Inventors: Michael O'Neill, Barbara Kidon, William A. Janz, Hongqiao Wu
  • 2,2,2-TRIFLUOROACETIC ACID 1-(2,4-DIMETHYLPHENYL)-2-[(3-METHOXYPHENYL)METHYLENE] HYDRAZIDE POLYMORPHS AND METHOD OF MAKING THE SAME
    Publication number: 20210139416
    Abstract: Crystalline polymorph forms of neurotrophic agent 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide (J147), and process for producing the crystalline polymorphic form are provided.
    Type: Application
    Filed: January 17, 2021
    Publication date: May 13, 2021
    Inventors: Michael O'NEILL, Barbara KIDON, William A. JANZ, Hongqiao WU
  • 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene] hydrazide polymorphs and method of making the same
    Patent number: 10968167
    Abstract: Crystalline polymorph forms of neurotrophic agent 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide (J147), and process for producing the crystalline polymorphic form are provided.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: April 6, 2021
    Assignee: ABREXA PHARMACEUTICALS, INC.
    Inventors: Michael O'Neill, Barbara Kidon, William A. Janz, Hongqiao Wu
  • Alpha-tea salt forms: compositions and uses for treating disease
    Patent number: 10934267
    Abstract: The present disclosure relates to salts of the compound: polymorphic forms thereof, methods for preparation and use thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: March 2, 2021
    Assignee: Research Development Foundation
    Inventors: Michael O'Neill, Barbara Kidon, Thomas Adkins, Hongqiao Wu, Emmanuel T. Akporiaye
  • 2,2,2-TRIFLUOROACETIC ACID 1-(2,4-DIMETHYLPHENYL)-2-[(3-METHOXYPHENYL)METHYLENE] HYDRAZIDE POLYMORPHS AND METHOD OF MAKING THE SAME
    Publication number: 20200399205
    Abstract: Crystalline polymorph forms of neurotrophic agent 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide (J147), and process for producing the crystalline polymorphic form are provided.
    Type: Application
    Filed: February 20, 2019
    Publication date: December 24, 2020
    Inventors: Michael O'NEIL, Barbara KIDON, Bill JANZ, Hongqiao WU
  • ALPHA-TEA SALT FORMS: COMPOSITIONS AND USES FOR TREATING DISEASE
    Publication number: 20200148661
    Abstract: The present disclosure relates to salts of the compound: polymorphic forms thereof, methods for preparation and use thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: June 18, 2019
    Publication date: May 14, 2020
    Applicant: Research Development Foundation
    Inventors: Michael O'NEILL, Barbara KIDON, Thomas ADKINS, Hongqiao WU, Emmanuel T. AKPORIAYE
  • Alpha-TEA salt forms: compositions and uses for treating disease
    Patent number: 10370350
    Abstract: The present disclosure relates to salts of the compound (I), polymorphic forms thereof, methods for preparation and use thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: August 6, 2019
    Assignee: Research Development Foundation
    Inventors: Michael O'Neill, Barbara Kidon, Thomas Adkins, Hongqiao Wu, Emmanuel T. Akporiaye
  • ALPHA-TEA SALT FORMS: COMPOSITIONS AND USES FOR TREATING DISEASE
    Publication number: 20160214954
    Abstract: The present disclosure relates to salts of the compound (I), polymorphic forms thereof, methods for preparation and use thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: September 5, 2014
    Publication date: July 28, 2016
    Applicant: Research Development Foundation
    Inventors: Michael O'NEILL, Barbara KIDON, Thomas ADKINS, Hongqiao WU, Emmanuel T. AKPORIAYE